ID
34364
Beschreibung
Study ID: 101682 Clinical Study ID: B2E101682 Study Title: A randomised, double-blind, placebo-controlled, parallel group study to examine the safety, tolerability, and pharmacokinetics of repeat inhaled doses of GSK159797 in healthy subjects. Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: milveterol Trade Name: milveterol Study Indication: Pulmonary Disease, Chronic Obstructive. This form contains information about non-serious adverse events and should only be completed in case of occurence of non-serious adverse events.
Stichworte
Versionen (2)
- 16.01.19 16.01.19 -
- 16.01.19 16.01.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
16. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Safety, tolerability and pharmacokinetics of repeat inhaled doses of milveterol in healthy subjects (Study ID: 101682)
Non-Serious Adverse Events
- StudyEvent: ODM
Beschreibung
Non-Serious adverse events
Alias
- UMLS CUI-1
- C1518404
Beschreibung
If YES, indicate below
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1518404
Beschreibung
Diagnosis or signs/symptoms of NSAE
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0011900
- UMLS CUI [1,2]
- C0037088
- UMLS CUI [1,3]
- C1518404
Beschreibung
Date of onset NSAE
Datentyp
date
Maßeinheiten
- dd.mm.yyyy
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C1518404
Beschreibung
Time of onset NSAE
Datentyp
time
Maßeinheiten
- hh:mm
Alias
- UMLS CUI [1,1]
- C0449244
- UMLS CUI [1,2]
- C1518404
Beschreibung
Maximum Intensity NSAE
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0518690
- UMLS CUI [1,2]
- C1518404
Beschreibung
Outcome SAE
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1705586
- UMLS CUI [1,2]
- C1518404
Beschreibung
Date of resolution
Datentyp
date
Maßeinheiten
- dd.mm.yyyy
Alias
- UMLS CUI [1,1]
- C2985918
- UMLS CUI [1,2]
- C1518404
Beschreibung
Time of resolution
Datentyp
time
Maßeinheiten
- hh:mm
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C2699488
- UMLS CUI [1,3]
- C1518404
Beschreibung
Investigational drug, change of dose as a result of NSAE
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C1608430
- UMLS CUI [1,3]
- C1518404
Beschreibung
Withdrawal from study as result of NSAE
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1710677
- UMLS CUI [1,2]
- C1518404
Beschreibung
Relationship to investigational product
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0085978
- UMLS CUI [1,3]
- C0013230
Beschreibung
In this study, the answer 'No' was preselected.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1704788
- UMLS CUI [1,2]
- C1710056
Ähnliche Modelle
Non-Serious Adverse Events
- StudyEvent: ODM
C0037088 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C2699488 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C1608430 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C0085978 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C1710056 (UMLS CUI [1,2])